Clinical trial
Combination Chemotherapy Plus Fluoxetine in Treating Patients With Advanced or…
NCT00005850 · Alliance for Clinical Trials in Oncology, Other · Completed
Key facts
| NCT number | NCT00005850 |
|---|---|
| Title | Combination Chemotherapy Plus Fluoxetine in Treating Patients With Advanced or Recurrent Non-Small Cell Lung Cancer |
| Official title | Fluoxetine in Stage IIIB/IV Non-Small Cell Lung Cancer (NSCLC): A Phase II Pilot Study to Improve Quality of Life During Chemotherapy |
| Lead sponsor | Alliance for Clinical Trials in Oncology, Other |
| Collaborators | National Cancer Institute (NCI) NIH |
| Status | Completed |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Anxiety Disorder, Depression, Fatigue, Lung Cancer |
| Intervention type | Drug |
| Interventions | cisplatin, fluoxetine, gemcitabine hydrochloride |
| Enrollment | 21 |
| Start date | Aug 1, 2001 |
| Primary completion | Sep 1, 2003 |
| Completion | Sep 1, 2003 |
| First posted | Jan 27, 2003 |
| Last update posted | Jul 4, 2016 |
| Countries | Puerto Rico, United States |
At a glance
- 10–99 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: